Brand Name(s): Glauctabs; MZM; Neptazane
CAS nš: 554-57-4
(meth a ZOLE a mide)
About Methazolamide
This new site is dedicated exclusively to methazolamide.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about methazolamide on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.
This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total methazolamide experience!
Why is this medication prescribed?
Methazolamide is a carbonic anhydrase inhibitor. Carbonic anhydrase is a protein in the body, and this medication works by reducing the activity of this particular protein.
Furthermore, this medicine is used to treat glaucoma. By inhibiting the actions of carbonic anhydrase, methazolamide reduces the amount of fluid produced in the eyes and therefore also reduces pressure.
Latest News
Americans are out of focus on proper vision care
One in four African-Americans have not had an eye exam in at least two years.
[more]Weightlifting May Increase Glaucoma Risk
If you are a regular weightlifter perhaps you should bear in mind that you could be increasing your...
[more]Glaucoma steals your sight
In what's become almost a weekly occurrence at Brilliant Eyecare at the Clock Tower Place in...
[more]Latest Glaucoma innovations
Just a few years ago, glaucoma was thought to be solely a disease of high pressure inside the...
[more]Representing Methazolamide
Methazolamide (Generic: Neptazane) was approved by the FDA on August 28, 1996 and is manufactured...
[more]